pyrazinamide has been researched along with Acute Yellow Atrophy in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 10-year-old child treated for latent tuberculosis infection (LTBI) with pyrazinamide (PZA) and levofloxacin after contact with a smear-positive multidrug-resistant tuberculosis adult." | 3.91 | Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin. ( Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huguet, A | 1 |
| Ader, F | 1 |
| Ohlmann, C | 1 |
| Collardeau-Frachon, S | 1 |
| Gillet, Y | 1 |
| SPENGOS, TN | 1 |
| CUIZON, R | 1 |
2 other studies available for pyrazinamide and Acute Yellow Atrophy
| Article | Year |
|---|---|
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; | 2019 |
Pyrazinamide-induced acute yellow atrophy of the liver: case report and post-mortem findings.
Topics: Humans; Massive Hepatic Necrosis; Niacin; Nicotinic Acids; Pyrazinamide | 1958 |